关键字: 类型:
下载页码(大于等于0,小于445):
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 
 生物仿制药产品开发 1451条(本栏目收费,不能显示细节,电话13136136841)
due diligence,430 430 
trial design,208 208 
Enoxaparin,70 70 
enzyme-linked immunosorbent assay (ELISA),61,442 61 442 
EPO see Erythropoietin epoetin,404 404 
epoetin alfa immunogenicity,202–203 202 203 
naming and tracking,369 369 
nonclinical studies,343 343 
product quality variables,335 335 
sensitive study population,348,350 348 350 
switching,350 350 
epoetin alfa BS,232 232 
Eprex,365–366 365 366 
Eprex/Erypo,202–203 202 203 
equivalence limit,103 103 
equivalence margins,277 277 
equivalence test,95–97,163–165 95 97 163 165 
equivalence trials,271,278 271 278 
Erbitux,133,203 133 203 
errors,34,105,419–420 34 105 419 420 
erythropoietin (EPO)background,110 110 
glycosylation,120–121 120 121 
inconsistencies apparent,168 168 
interchangeability,290 290 
market experience,427 427 
pharmacokinetics,205 205 
product class-specific guidelines,228 228 
safety profile uncertainties,365–366 365 366 
Escherichia coli,155,442 155 442 
ESI see Electrospray ionization etanercept see also Enbrel case study,201 201 
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3